Colgate-Palmolive Company (CL)
| Market Cap | 79.23B +25.1% |
| Revenue (ttm) | 21.29B +5.9% |
| Net Income | 2.05B -29.4% |
| EPS | 2.56 -28.3% |
| Shares Out | 794.92M |
| PE Ratio | 38.92 |
| Forward PE | 24.95 |
| Dividend | $2.12 (2.13%) |
| Ex-Dividend Date | Oct 20, 2026 |
| Volume | 5,496,032 |
| Open | 98.50 |
| Previous Close | 97.90 |
| Day's Range | 98.05 - 99.75 |
| 52-Week Range | 75.96 - 101.18 |
| Beta | 0.31 |
| Analysts | Buy |
| Price Target | 101.70 (+2.04%) |
| Earnings Date | Oct 30, 2026 |
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2025, Colgate-Palmolive Company's revenue was $20.38 billion, an increase of 1.40% compared to the previous year's $20.10 billion. Earnings were $2.13 billion, a decrease of -26.20%.
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for CL stock is "Buy." The 12-month stock price target is $101.7, which is an increase of 2.04% from the latest price.
News
3 ‘Strong Buy’ Dividend Aristocrat Stocks to Watch, According to Top Analysts
Chevron ($CVX), Colgate-Palmolive ($CL), and Albemarle ($ALB) are three Dividend Aristocrat stocks, each rated a Strong Buy by top Wall Street analysts, according to TipRanks’ Dividend Aristocrats too...
Colgate-Palmolive price target raised to $95 from $87 at Barclays
Barclays raised the firm’s price target on Colgate-Palmolive (CL) to $95 from $87 and keeps an Equal Weight rating on the shares.
Colgate-Palmolive price target raised to $108 from $97 at BNP Paribas
BNP Paribas raised the firm’s price target on Colgate-Palmolive (CL) to $108 from $97 and keeps an Outperform rating on the shares.
Colgate Women's Games Launches Season 51, Honoring Decades of Empowering Athletes
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive announced today that registration is officially open for the 51st season of Colgate Women's Games (CWG), the nation's longest-running indoor track & field ...
Colgate-Palmolive price target raised to $97 from $90 at TD Cowen
TD Cowen raised the firm’s price target on Colgate-Palmolive (CL) to $97 from $90 and keeps a Hold rating on the shares. The firm updated its model following Q3 results…
Colgate-Palmolive price target lowered to $102 from $104 at JPMorgan
JPMorgan lowered the firm’s price target on Colgate-Palmolive (CL) to $102 from $104 and keeps an Overweight rating on the shares.
Colgate-Palmolive price target raised to $95 from $90 at Wells Fargo
Wells Fargo raised the firm’s price target on Colgate-Palmolive (CL) to $95 from $90 and keeps an Equal Weight rating on the shares. The firm views the company’s Q3 report…
Colgate-Palmolive price target raised to $105 from $100 at BofA
BofA raised the firm’s price target on Colgate-Palmolive (CL) to $105 from $100 and keeps a Buy rating on the shares. The firm views the company’s Q3 report as solid.
Colgate-Palmolive price target raised to $111 from $104 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Colgate-Palmolive (CL) to $111 from $104 and keeps an Overweight rating on the shares. The firm views the company’s Q3 report as…
Colgate-Palmolive price target raised to $112 from $106 at UBS
UBS analyst Peter Grom raised the firm’s price target on Colgate-Palmolive (CL) to $112 from $106 and keeps a Buy rating on the shares. The company reported a Q3 earnings…
Colgate-Palmolive price target raised to $103 from $100 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Colgate-Palmolive (CL) to $103 from $100 and keeps a Buy rating on the shares. The company’s Q3 earnings beat and FY26 guidance…
Colgate-Palmolive Company Earnings Call Transcript: Q3 2026
Broad-based growth and improved gross-margin guidance reflected pricing, productivity and premium innovation, despite persistent cost inflation and freight pressures. Emerging markets and Hill's led performance, while U.S. recovery and Mexico remain priorities.
Colgate-Palmolive Company Earnings release: Q3 2026
Colgate-Palmolive Company released its Q3 2026 earnings on October 30, 2026, summarizing the period's financial results.
Colgate-Palmolive Company Slides: Q3 2026
Colgate-Palmolive Company has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 30, 2026.
Colgate-Palmolive Company Prepared remarks: Q3 2026
Colgate-Palmolive Company filed a regulatory document on October 30, 2026 disclosing important business information.
Colgate-Palmolive Company Quarterly report: Q3 2026
Colgate-Palmolive Company has published its Q3 2026 quarterly earnings report on October 30, 2026.
Colgate-Palmolive Posts Higher Profit, Sales
Colgate-Palmolive said profit and sales climbed in the recent quarter, boosted by higher volumes and prices despite ongoing uncertainty.
Colgate-Palmolive Announces 3rd Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 4.6%; Organic sales* increased 3.6%, including a 0.2% negative impact from lower private label pet food sales GAAP E...
Mapping the Market: Colgate-Palmolive shares look ready to extend rally
Shares in Colgate-Palmolive have gained more than 13% over the last three weeks or so. That rise could be a sign of building momentum for another leg higher, technical analysis suggests.
Investors' search for safety has made toothpaste stocks more expensive than tech
Wall Street is fleeing tech for toothpaste and shampoo. Even those stocks are getting expensive.
Colgate-Palmolive price target raised to $104 from $103 at JPMorgan
JPMorgan raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $103 and keeps an Overweight rating on the shares. The firm adjusted targets in the beverage, household and…
Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.
Goldman Sachs says consumer-facing laggard stocks are the best way forward as earnings growth is set to slow next year and big tech stocks struggle.
Colgate-Palmolive Webcasts 2026 Third Quarter Earnings Conference Call October 30, 2026 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 third quarter earnings conference call on Friday, October 30, 2026, at 8:30 a.m. ET. The call wil...
Colgate-Palmolive price target lowered to $106 from $109 at UBS
UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $106 from $109 and keeps a Buy rating on the shares.
Colgate-Palmolive price target lowered to $100 from $102 at BofA
BofA lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $102 and keeps a Buy rating on the shares. Many of the same debates weighing on consumer staples…